Literature DB >> 30820043

Metabolic interventions in the immune response to cancer.

David O'Sullivan1,2, David E Sanin1,2, Edward J Pearce3,4, Erika L Pearce5.   

Abstract

At the centre of the therapeutic dilemma posed by cancer is the question of how to develop more effective treatments that discriminate between normal and cancerous tissues. Decades of research have shown us that universally applicable principles are rare, but two well-accepted concepts have emerged: first, that malignant transformation goes hand in hand with distinct changes in cellular metabolism; second, that the immune system is critical for tumour control and clearance. Unifying our understanding of tumour metabolism with immune cell function may prove to be a powerful approach in the development of more effective cancer therapies. Here, we explore how nutrient availability in the tumour microenvironment shapes immune responses and identify areas of intervention to modulate the metabolic constraints placed on immune cells in this setting.

Entities:  

Mesh:

Year:  2019        PMID: 30820043     DOI: 10.1038/s41577-019-0140-9

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  74 in total

Review 1.  Fueling the Revolution: Targeting Metabolism to Enhance Immunotherapy.

Authors:  Robert D Leone; Jonathan D Powell
Journal:  Cancer Immunol Res       Date:  2021-03       Impact factor: 11.151

2.  Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer.

Authors:  Deanna N Edwards; Verra M Ngwa; Ariel L Raybuck; Shan Wang; Yoonha Hwang; Laura C Kim; Sung Hoon Cho; Yeeun Paik; Qingfei Wang; Siyuan Zhang; H Charles Manning; Jeffrey C Rathmell; Rebecca S Cook; Mark R Boothby; Jin Chen
Journal:  J Clin Invest       Date:  2021-02-15       Impact factor: 14.808

Review 3.  Industrializing engineered autologous T cells as medicines for solid tumours.

Authors:  Cedrik M Britten; Aiman Shalabi; Axel Hoos
Journal:  Nat Rev Drug Discov       Date:  2021-04-08       Impact factor: 84.694

Review 4.  Advances into understanding metabolites as signaling molecules in cancer progression.

Authors:  Joyce Y Liu; Kathryn E Wellen
Journal:  Curr Opin Cell Biol       Date:  2020-02-22       Impact factor: 8.382

Review 5.  Arginine depriving enzymes: applications as emerging therapeutics in cancer treatment.

Authors:  Neha Kumari; Saurabh Bansal
Journal:  Cancer Chemother Pharmacol       Date:  2021-07-26       Impact factor: 3.333

Review 6.  Nitrogen Metabolism in Cancer and Immunity.

Authors:  Kiran Kurmi; Marcia C Haigis
Journal:  Trends Cell Biol       Date:  2020-03-10       Impact factor: 20.808

7.  Stanniocalcin 1 is a phagocytosis checkpoint driving tumor immune resistance.

Authors:  Heng Lin; Ilona Kryczek; Shasha Li; Michael D Green; Alicia Ali; Reema Hamasha; Shuang Wei; Linda Vatan; Wojciech Szeliga; Sara Grove; Xiong Li; Jing Li; Weichao Wang; Yijian Yan; Jae Eun Choi; Gaopeng Li; Yingjie Bian; Ying Xu; Jiajia Zhou; Jiali Yu; Houjun Xia; Weimin Wang; Ajjai Alva; Arul M Chinnaiyan; Marcin Cieslik; Weiping Zou
Journal:  Cancer Cell       Date:  2021-01-28       Impact factor: 31.743

Review 8.  Metabolites and the tumour microenvironment: from cellular mechanisms to systemic metabolism.

Authors:  Ilaria Elia; Marcia C Haigis
Journal:  Nat Metab       Date:  2021-01-04

Review 9.  Immunometabolic Interplay in the Tumor Microenvironment.

Authors:  Irem Kaymak; Kelsey S Williams; Jason R Cantor; Russell G Jones
Journal:  Cancer Cell       Date:  2020-10-29       Impact factor: 31.743

Review 10.  Moving Immune Therapy Forward Targeting TME.

Authors:  Kayla F Goliwas; Jessy S Deshane; Craig A Elmets; Mohammad Athar
Journal:  Physiol Rev       Date:  2020-08-13       Impact factor: 37.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.